Woodline Partners’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-222,462
| Closed | -$2.14M | – | 659 |
|
|
2023
Q4 | $2.14M | Buy |
222,462
+144,427
| +185% | +$1.39M | 0.02% | 371 |
|
|
2023
Q3 | $203K | Buy |
+78,035
| New | +$203K | ﹤0.01% | 553 |
|
|
2022
Q2 | – | Sell |
-25,703
| Closed | -$200K | – | 914 |
|
|
2022
Q1 | $200K | Sell |
25,703
-217,637
| -89% | -$1.69M | ﹤0.01% | 551 |
|
|
2021
Q4 | $1.02M | Buy |
243,340
+88,719
| +57% | +$370K | 0.01% | 501 |
|
|
2021
Q3 | $1.23M | Buy |
154,621
+24
| +0% | +$190 | 0.02% | 486 |
|
|
2021
Q2 | $1.25M | Buy |
154,597
+30,003
| +24% | +$242K | 0.02% | 413 |
|
|
2021
Q1 | $1.34M | Buy |
124,594
+71,767
| +136% | +$770K | 0.03% | 343 |
|
|
2020
Q4 | $621K | Sell |
52,827
-23,266
| -31% | -$274K | 0.02% | 213 |
|
|
2020
Q3 | $915K | Sell |
76,093
-43,907
| -37% | -$528K | 0.03% | 173 |
|
|
2020
Q2 | $2.1M | Buy |
+120,000
| New | +$2.1M | 0.08% | 134 |
|